Abstract:The GPR52, a class A orphan G protein-coupled receptor (GPCR), is regarded as a promising therapeutic target for the treatment of Huntington's disease and multiple psychiatric disorders. Although the recently solved structure of GPR52 has revealed a binding mechanism likely shared by all reported agonists, the small molecule antagonist E7 cannot fit into this agonist-binding pocket, and its interaction mode with the receptor remains unknown. Here, we employed targeted proteomics and affinity mass spectrometry approaches to uncover a unique binding mode of E7 which acts as a covalent and allosteric ligand of GPR52. Among three Cys residues identified in this study to form covalent conjugates with E7, the intracellular C156<sup>4.40</sup> makes the most significant contribution to the antagonism activity of E7. Discovery of this novel intracellular site for covalent attachment of an antagonist would facilitate the design of GPR52-selective negative allosteric modulators which could serve as potential therapeutics for treating Huntington's disease.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00867?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00867</a>.(Figure S1) Purification of the GPR52 protein; (Figure S2) structure and cell activity of a newly synthesized GPR52 antagonist (Comp-43); (Figure S3) E7 is covalently conjugated to GPR52 expressed in live cells; (Figure S4) molecular docking of reported agonists into the agonist-binding side pocket in the GPR52 structure; (Figure S5) surface expression levels of WT and mutant GPR52 as determined by FACS staining of HEK293/HA-GPR52 cells; (Table S1) targeted MS peak intensities of E7-modified peptides and unmodified counterparts from purified GPR52 protein; (Table S2) targeted MS peak intensities of E7-modified peptides and unmodified counterparts from GPR52 in live cells; (Table S3) targeted MS peak intensities of E7-modified peptides and unmodified counterparts from purified GPR52 protein pretreated with or without 7m (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00867/suppl_file/cb0c00867_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Post-translational modifications orchestrate the intrinsic signaling bias of orphan receptor GPR52

Two naturally occurring mutations of human GPR103 define distinct G protein selection bias

Dynamic Insights into the Self-Activation Pathway and Allosteric Regulation of the Orphan G-Protein-Coupled Receptor GPR52

Phospho-selective Mechanisms of Arrestin Conformations and Functions Revealed by Unnatural Amino Acid Incorporation and 19F-NMR

Structural basis of ligand recognition and self-activation of orphan GPR52

Activation and Allosteric Regulation of the Orphan GPR88-Gi1 Signaling Complex.

Distinct Conformations of GPCR–β-arrestin Complexes Mediate Desensitization, Signaling, and Endocytosis

G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors

Exploring the constitutive activation mechanism of the class A orphan GPR20

Specific binding of GPR174 by endogenous lysophosphatidylserine leads to high constitutive Gs signaling

A Striatal-Enriched Intronic GPCR Modulates Huntingtin Levels and Toxicity

Structure basis of ligand recognition and activation of GPR55

Allosteric mechanisms underlie GPCR signaling to SH3-domain proteins through arrestin

Posttranslational modifications in GPCR internalization

GPCR activation and GRK2 assembly by a biased intracellular agonist

Targeted Proteomics Combined with Affinity Mass Spectrometry Analysis Reveals Antagonist E7 Acts As an Intracellular Covalent Ligand of Orphan Receptor GPR52

Phosphorylation of G Protein-Coupled Receptors: from the Barcode Hypothesis to the Flute Model

Cryo-EM structures of orphan GPR21 signaling complexes

Spatiotemporal Control of GPR37 Signaling and Its Behavioral Effects by Optogenetics

Posttranslational Regulation Of G Protein-Coupled Receptors

Orphan GPR52 as an emerging neurotherapeutic target